Finding usable portion of sigmoid curve

Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Chemical analysis

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C702S019000

Reexamination Certificate

active

07469186

ABSTRACT:
Various technologies are described by which the usable portion or threshold value of a sigmoid curve is found. Such techniques can be useful, for example, when determining the concentration or presence of a substance in a test sample. Various techniques can avoid variability in results.

REFERENCES:
patent: 4703017 (1987-10-01), Campbell et al.
patent: 4835099 (1989-05-01), Mize et al.
patent: 5616504 (1997-04-01), Brown et al.
patent: 5795791 (1998-08-01), Hirai et al.
patent: 5948368 (1999-09-01), Hirai et al.
patent: 6188969 (2001-02-01), Minor
patent: 6277584 (2001-08-01), Chu et al.
patent: 6303305 (2001-10-01), Wittwer et al.
patent: 6395480 (2002-05-01), Hefti
patent: 6403314 (2002-06-01), Lange et al.
patent: 6436721 (2002-08-01), Kuo et al.
patent: 6440667 (2002-08-01), Fodor et al.
patent: 6503720 (2003-01-01), Wittwer et al.
patent: 6514770 (2003-02-01), Sorin
patent: 6887710 (2005-05-01), Call et al.
patent: 7373253 (2008-05-01), Eyre
patent: 2002/0034732 (2002-03-01), Capon et al.
patent: 2002/0082386 (2002-06-01), Mangold et al.
patent: 2002/0160012 (2002-10-01), Kaastrup
patent: 2003/0157498 (2003-08-01), Eyre et al.
Becking, L.G.M.Baas, “On the Analysis of Sigmoid Curves”. Mar. 1946, Acta Biotheoretica, vol. 8, Nos. 1-2, pp. 42-59.
“DeCypher Introduction, The Complete Solution for Accelerated Biocomputing,” TimeLogic Corporation, http://www.timelogic.com/decypher—intyo.html, 3 pages, website visited on Oct. 22, 2002.
“ELISA Activity—ELISA data from three patients,”The Biology Project—Immunology, The University of Arizona, http://www.biology.arizona.edu/immunology/activities/elisa/elisa1.html, 1 page, website visited Oct. 22, 2002.
“ELISA Activity—False Positives,”The Biology Project—Immunology, The University of Arizona, http://www.biology.arizona.edu/immunology/activities/elisa/false.html, 1 page, website visited Oct. 22, 2002.
“ELISA Activity—The ELISA Method,”The Biology Project—Immunology, The University of Arizona, http://www.biology.arizona.edu/immunology/activities/elisa/technique.html, 1 page, website visited Oct. 22, 2002.
“ELISA Activity—The ELISA,”The Biology Project—Immunology, The University of Arizona, http://www.biology.arizona.edu/immunology/activities/elisa/elisa—intro.html, 1 page, website visited Oct. 22, 2002.
“Enhancing Human Health Through Better Decisions—from Discovery Through Development to Commercialization—and Beyond,” SAS Institute Inc., 2 pages, http://www.sas.com/industry/pharma/index.html, website visited on Oct. 22, 2002.
“Enzyme-Linked Immunosorbent Assay,”Emerging Infectious Diseases, vol. 8, No. 10. CDC, 3 pages, 2002.
“General Policy Issues,”WHO Drug Information, vol. 14, No. 1, pp. 1-38, 2000.
“PROC NLIN Statement,” SAS Institute Inc., 5 pages, http://www.id.unizh.ch/software/unix/statmath/sas/sasdoc/stat/chap45/sect4.htm, Copyright 1999.
“Product Information: Prospect Pro: PROtein Structure Prediction and Evaluation Computer Toolkit,” Bioinformatics Solutions Inc., 2 pages, http://www.bioinformaticssolutions.com/products/prospect.php, website visited Oct. 22, 2002.
“StatLIA Main Page: StatLIA Software,” Brendan Scientific Corporation, 3 pages, http://www.brendan.com/sl—main.htm, website visited on Oct. 22, 2002.
“Using the ELISA Assay for Disease Detection—Student Handout,” The University of Arizona, Biotech Project, http://biotech.biology.arizona.edu/labs/ELISA—assay—students.html, 4 pages, website visited Oct. 22, 2002.
“Worldwide Cellular Assays Market Expected to Reach $500 Million on 2007,” Front Line Strategic Consulting Inc., http://www.the-infoshop.com/press/fe10229—en.shtml, 2 pages, website visited on Oct. 22, 2002.
“Zeus Scientific, Inc.—Technical Topics & Algorithms,” Zeus Scientific, Inc., 1 page, http://www.zeusssci.com/tech.html, website visited on Oct. 22, 2002.
Costa, “CDC Set To Begin Wide-Reaching Anthrax Vaccine Studies This Month,”Inside The Pentagon, http://www.marjorbates.com
ews/08mar01—itp.htm, 7 pages, Mar. 8, 2001.
Guarino et al., “A High Throughput, Cell-Based Assay for Metabolic Toxicity,” http://www.bdbiosciences.com/discovery—labware/Products/drug—discovery/polystyrene—microplates/oxygen—biosensor—system/pdf/O2—Metabotox-GordonConf.pdf, 1 page, GenTest Corporation, website visited Jan. 10, 2003.
Henderson, “Chapter 5: Affinity Separations” in Combined Microfiltration and Membrane-Based Affinity Separation Thesis, pp. 108-121, http://website.lineone.net/˜jim.henderson/work/dphil.html, 1999.
Marshall et al., “Lack of Autoantibody Production Associated with Cytomegalovirus,”Arthritis Res, 4:R6, http://arthritis-research.com/4/5/R6, 5 pages, 2002.
O'Connell, et al., “Calibration and Assay Development Using the Four-Parameter Logistic Model,”Chemometrics and Intelligent Laboratory Systems, vol. 20, Issue 2, Elsevier Science B.V., pp. 97-200, Sep. 1993.
Peterson, “Chapter 6 Data Fitting,” inNumerical Analysis: Adventures in Frustration, 15 pages, http://www.ces.clemson.edu/˜petersj/Agents/MatLabNA/MatLabNA006.html, website visited Mar. 12, 2003.
Phizicky et al., “Protein-Protein Interactions: Methods for Detection and Analysis,”Microbiological Reviews, vol. 59, No. 1, pp. 94-123, Mar. 1995.
Quinn et al., “Specific, Sensitive, and Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobin G Antibodies to Anthrax Toxin Protective Antigen,”Bioterrorism-Related Anthrax, vol. 8, No. 10, 15 pages, http://www.cdc.gov
cidod/EID/vol8no10/02-0380.htm, Oct. 2002.
Quinn et al., “Specific, Sensitive, and Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen,”Bioterrorism-Related Anthrax, vol. 8, No. 10, 3 pages, http://www.cdc.gov
cidod/EID/vol8no10/02-0380-G1.htm, Oct. 2002.
Strandh, “Insights Into Weak and Affinity Antibody-Antigen Interactions: Studies and Affinity Chromatography and Optical Biosensor,” Printed in Sweden at the University of Kalmar, 59 pages, 2000.
Yuancai et al., “Remarks on Height-Diameter Modeling,” United States Department of Agriculture, Research Note SRS-IO, 8 pages, Nov. 2001.
Examination Report, Australian Government—IP Australia, from counterpart Australian Application No. 2004224317, Jan. 21, 2008, 3 pages.
Taylor et al., “Novel Mathematical approach to TNA endpoints,” 5thIntl. Conf. Anthrax, 3rdInt. Workshop Mol. Biol.Bacillus cereus B. anthracis B. thuringiensis, Mar. 30, 2003-Apr. 4, 2003, 3 pages.
Taylor et al., “Novel Mathematical approach to TNA endpoints (Poster),” 5thIntl. Conf. Anthrax, 3rdInt. Workshop Mol. Biol.Bacillus cereus B. anthracis B. thuringiensis, Mar. 30, 2003-Apr. 4, 2003, 1 page.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Finding usable portion of sigmoid curve does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Finding usable portion of sigmoid curve, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Finding usable portion of sigmoid curve will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4027652

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.